Data for Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis (Study ST001748)
(Analysis AN002847)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 | F3 | F4 | F5 | F6 | F7 |
|---|---|---|---|---|---|---|---|
| Chenodeoxycholate | NA | NA | NA | 0.0869 | 1.3778 | 1.3741 | 1.4750 |
| Cholate | NA | NA | NA | 0.3756 | 1.0943 | 1.7234 | 1.1918 |
| Deoxycholate | 2.9921 | NA | 0.0042 | 0.1217 | 0.0513 | 0.0845 | 0.2496 |
| Lithocholate | 0.0530 | NA | 0.0027 | 0.8320 | 1.3482 | 1.7071 | 1.9434 |
| Ursodeoxycholate | NA | NA | NA | 0.0526 | 1.6295 | 1.7185 | 0.9854 |
| α-Muricholate | NA | NA | NA | 0.0220 | 1.9131 | 1.4534 | 0.8901 |
| β-Muricholate | NA | NA | NA | 0.0225 | 1.6624 | 1.7025 | 0.9980 |
Factors:
| F1 | Treatment:After 2 wk GUT/PBS therapy |
| F2 | Treatment:After GUT108/PBS therapy |
| F3 | Treatment:Before GUT108/PBS therapy (baseline) |
| F4 | Treatment:EER bacterial strains |
| F5 | Treatment:EER plus GUT-103 |
| F6 | Treatment:GUT103 |
| F7 | Treatment:GUT-103 plus EER |
